In Other News

• AI Pre-Screening Helps Identify Lung Cancer Cases for Additional Biomarker Testing

• Liquid Biopsy Detects Lung Cancer Recurrence Signals Months Before Imaging

• Two-Step Blood Testing Approach Reduces Uncertainty in Amyloid Assessment

• New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

• Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

• Multimodal Platform to Combine Blood and Imaging Biomarkers for Lung Nodule Assessment

• AI Pathology Platform Targets Workflow Delays and Molecular Test Failures

• GeneDx Presents Evidence for Wider Clinical Use of Genomic Sequencing at ASHG 2026

• New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

• Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

• Streamlined Genetic Testing Speeds Pediatric Immune Disorder Diagnosis

• Study Links Saliva-Based Epigenetic Signals to OCD Treatment Outcomes

• Genomic Tool Supports Analysis of Repeat Expansions Linked to Inherited Disorders

• Myriad Genetics to Sell Prenatal Testing Portfolio to Labcorp

• Managed Care Report Examines Barriers to Breast Cancer Biomarker Testing

• Immune Profiling Initiative Aims to Improve Bone Marrow Analysis in Leukemia

• Clinical Trial Evaluates Liquid Biopsy for Early-Stage Breast Cancer Detection

• CSF Biomarker Meprin-Beta Increases in Alzheimer’s Disease

• Expanding Screening and Biomarker Testing Drive Cancer Diagnostics Market Growth

• Molecular Panel Gains WHO Emergency Use Listing to Support Ebola Outbreak Response

• Collaboration Advances Genomic Instability Biomarker for Prostate Cancer

• Labcorp Acquisition to Strengthen Specialty Testing and Prostate Cancer Assessment

• Immune Profiling Initiative Aims to Improve Bone Marrow Analysis in Leukemia